《經濟數據》日本1月國內企業商品價按月回升0.6% 高預期
日本央行數據顯示,經季節調整後,日本2022年1月國內企業商品物價指數(CGPI)按月回升0.6%(前值上修爲零增長),高於市場預期回升0.4%;按年升幅進一步略放緩至8.6%(前值上修升幅僅由多年高位放緩至8.7%),仍高於市場預期升8.2%,且已連升11個月。
期內,以合同貨幣基準計算(下同)出口價格按月續降0.2%(前值略下修19個月來首降0.7%);按年升幅進一步放緩至6.6%(前值略下修僅續升8%),但已連升14個月。以合同貨幣基準計算(下同)進口價格按月轉降0.9%(前值上修轉爲續升0.2%),結束連升14個月;按年升幅進一步放緩至28%(前值上修升幅僅放緩至33.8%),但已連升11個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.